Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07807800) titled 'A Study of DES-1357 in People With Deficient Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer (mCRC)' on Sept. 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: D. E. Shaw Research, LLC

Condition: Metastatic Colorectal Cancer (CRC)

Intervention: Drug: DES-1357

Recruitment Status: Not recruiting

Phase: Phase 1/Phase 2

Date of First Enrollment: December 3, 2026

Target Sample Size: 88

To know more, visit https://clinicaltrials.gov...